Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Androgen Receptor Positive|Estrogen Receptor Negative|HER2/Neu Negative|Metastatic Triple-Negative Breast Carcinoma|Progesterone Receptor Negative|Stage IV Breast Cancer AJCC v6 and v7
Interventions: DRUG: Enobosarm|OTHER: Laboratory Biomarker Analysis|BIOLOGICAL: Pembrolizumab
Sponsor: City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)